All In Biotech

Free tool

FAERS Monitor: Temodar

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022277 or its brand name (Temodar, Temozolomide). Reports on generic versions are filed under their own applications.

Reports

21,320

Serious

17,250

81% of reports

Hospitalization

6,806

Death reported

4,502

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • disease progression1,895
  • off label use1,833
  • death1,811
  • thrombocytopenia1,592
  • product use in unapproved indication1,474
  • nausea1,332
  • drug ineffective1,270
  • fatigue1,050
  • neutropenia1,041
  • vomiting991
  • malignant neoplasm progression944
  • febrile neutropenia839
  • diarrhoea801
  • anaemia765
  • asthenia649

Reports by year received

View as table
YearReports
2004149
2005291
2006304
2007579
2008747
2009441
2010403
2011462
2012736
2013671
2014617
2015779
2016852
20171,041
20181,205
20191,170
20201,483
20211,560
20221,994
20231,746
20241,527
20251,524
20261,039

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,032,839 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
disease progressionSignal1,89516.015.426,431
thrombocytopeniaSignal1,59214.213.619,398
febrile neutropeniaSignal83912.611.88,884
malignant neoplasm progressionSignal9449.28.66,832
neutropeniaSignal1,0417.67.25,957
product use in unapproved indicationSignal1,4745.95.66,024
anaemiaSignal7654.03.71,705
vomitingSignal9912.12.0567
deathSignal1,8112.12.01,050
off label useSignal1,8332.12.01,051
asthenia6491.71.6191
nausea1,3321.71.6363
fatigue1,0501.31.389
diarrhoea8011.21.134
drug ineffective1,2701.00.93

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.